Abstract
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter involved in the control of various physiological functions and brain disorders, and its effects are mediated through several classes of specific 5-HT receptors (Osborne and Hamon, 1988). Indeed the demonstration of the heterogeneity of 5-HT receptors was reported as far back as 1957 (Gaddum and Picarelli, 1957), and became more evident during the past five years. To date, the development of radioligand binding techniques has established that 5-HT receptors are divided into three main classes, designated 5-HT1, 5-HT2 and 5-HT3, with different pharmacological properties, regional distributions, and functions in the central nervous system (CNS) (Bradley et al., 1986; Tricklebank, 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allgren, R. L., Kyncl, M. M. A., and Ciaranello, R. D. (1985) Brain Res. 348, 77–85.
Asarch, K. B. and Shih, J. C. (1987) J. Neurochem. 48,1494–1501.
Bouhelal, R., Smounya, L., and Bockaert, J. (1988) Eur. J. Pharmacol. 151,189–196.
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., and Saxena, P. R. (1986) Neuro-pharmacology 25, 563–576.
Brann, M. R. (1985) Biochem. Biophys. Res. Commun. 133, 1181–1186.
Bruns, R. F., Lawson-Wendling, K., and Pugsley, T. A. (1983) Anal. Biochem. 132, 74–81.
Chan, B. and Madras, B. K. (1982) Eur. J. Pharmacol. 83,1–10.
Cheng, S. H. and Shih, J. C. (1979) Life Sci. 25, 2197–2203.
Conn, P. J. and Sanders-Bush, E. (1985) J. Pharmacol. Exp. Ther. 234,195–203.
Conn, P. J., Sanders-Bush, E., Hoffman, B. J., and Hartig, P. R. (1986) Proc. Natl. Acad. Sci. USA 83, 4086–4088.
Cotecchia, S., Schwinn, D. A., Randall, R. R., Lefkowitz, R., Caron, M. G., and Kobilka, B. K. (1988) Proc. Natl. Acad. Sci. USA 85, 7159–7163.
Devivo, M. and Maayani, S. (1986) J. Pharmacol. Exp. Ther. 238, 248–253.
Dourish, C. T., Ahlenius, S., and Hutson, P. H. (1987) “Brain 5-HT IA Receptors,“ Ellis Horwood, Chichester, p. 306.
El Mestikawy, S., Cognard, C., Gozlan, H., and Hamon, M. (1988) J. Neurochem. 51, 1031–1040.
El Mestikawy, S., Taussig, D., Gozlan, H., Emerit, M. B., Ponchant, M., and Hamon, M. (1989) J. Neurochem. 53,1555–1566.
Emerit, M. B., Gozlan, H., Marquet, A., and Hamon, M. (1986) Eur. J. Pharmacol. 127, 67–81.
Emerit, M. B., El Mestikawy, S., Gozlan, H., Cossery, J. M., Besselievre, R., Marquet, A., and Hamon, M. (1987) J. Neurochem. 49,373–380.
Fargin, A., Raymond, J. R., Lohse, M. J., Kobilka, B. K., Caron, M. G., and Lefkowitz, R. J. (1988) Nature 335, 358–360.
Ferry, D. R., Goll, A., Glossmann, H., Glaser, T., and Traber, T. (1988) Neurosci. Res. Commun. 2,9–17.
Gaddum, J. H. and Picarelli, Z. P. (1957) Brit. J. Pharmacol. Chemother. 12, 323–328.
Gallaher, T. K. and Wang, H. H. (1988) Proc. Natl. Acad. Sci. USA 85,2378–2382.
Glossman, H. and Neville, D. M. (1971) J. Biol. Chem. 246, 6339–6346.
Gozlan, H., El Mestikawy, S., Pichat, L., Glowinski, J., and Hamon, M. (1983) Nature 305, 140–142.
Gozlan, H., Emerit, M. B., Hall, M. D., Nielsen, M., and Hamon, M. (1986) Biochem. Pharmacol. 35,1891–1897.
Gozlan, H., Emerit, M. B., El Mestikawy, S., Cossery, J. M., Marquet, A., Besselievre, R., and Hamon, M. (1987) J. Recept. Res. 7,195–221.
Hall, M. D., Gozlan, H., Emerit, M. B., El Mestikawy, S., Pichat, L., and Hamon, M. (1986) Neurochem. Res. 11, 891–912.
Hamblin, M. W., Ariani, K., Adriaenssens, P. I., and Ciaranello, R. D. (1987) J. Pharmacol. Exp. Ther. 243, 989–1001.
Hamon, M., Fattaccini, C. M., Adrien, J., Gallissot, M.-C., Martin, P., and Gozlan, H. (1988) J. Pharmacol. Exp. Ther. 246, 745–752.
Hamon, M. (1987) in “Pharmacology” (Rand, M. J. and Raper, C., eds.), Elsevier, Amsterdam, pp. 281–284.
Hamon, M., Emerit, M. B., El Mestikawy, S., Vergé, D., Daval, G., Marquet, A., and Gozlan, H. (1987) in “Brain 5-HT IA Receptors“ (Dourish, C. T., Alhenius, S., and Hutson, P. H., eds.),Horwood, Chichester, pp. 34–51.
Heuring, R. E. and Peroutka, S. J. (1987) J. Neurosci. 7, 894–903.
Hoyer, D., Engel, G., and Kalkman, H. O. (1985) Eur. J. Pharmacol. 118 13–23.
Hoyer, D. and Neijt, H. C. (1987) Eur. J. Pharmacol. 143, 291–292.
Hoyer, D. and Schoeffter, P. (1988) Eur. J. Pharmacol. 147,145–147.
Ilien, B., Gorissen, H., and Laduron, P. M. (1982) Mol. Pharmacol. 22, 243–249.
Ilien, B., Schotte, A., and Laduron, P. M. (1982a) FEBS Lett. 138 311–315.
Julius, D., MacDermott, A. B., Axel, R., and Jessell, T. M. (1988) Science 241 558–564.
Kendall, D. A. and Nahorski, S. R. (1985) J. Pharmacol. Exp. Ther. 233, 473–479.
Kilpatrick, G. J., Jones, B. J., and Tyers, M. B. (1987) Nature 330, 746–748.
Kobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T. L., Kobilka, T. S., Francke, U., Lefkowitz, R. J., and Caron, M. G. (1987) Nature 329, 75–79.
Kobilka, B. K., Matsui, H., Kobilka, T. S., Yang-Feng, T. L., Francke, U., Caron, M. G., Lefkowitz, R. J., and Regan, J. W. (1987a) Science 238, 650–656.
Kobilka, B. K., Kobilka, T. S., Daniel, K., Regan, J. W., Caron, M. G., and Lefkowitz, R. J. (1988) Science 240 1310–1316.
Leysen, J. E., Niemegeers, C. J. E., Van Nueten, J. M., and Laduron, P. M. (1982) 3H-Ketanserin (R 41468) Mol. Pharmacol. 21 301–314.
Lowe, M. E. and Kempner, E. S. (1982) J. Biol. Chem. 257,12478–12480.
Lübbert, H., Hoffman, B. J., Snutch, T. P., Van Dyke, T., Levine, A. J., Hartig, P. R., Lester, H. A., and Davidson, N. (1987) Proc. Natl. Acad. Sci. USA 84,4332–4336.
Lübbert, H., Snutch, T. P., Lester, H. A., and Davidson, N. (1987) J. Neuroscience 7, 1159–1165.
Nielsen, M. and Braestrup, C. (1988) J. Biol. Chem. 263,11900–11906.
Nishino, N. and Tanaka, C. (1985) Life Sci. 37,1167–1174.
Osborne, N. N. and Hamon, M. (1988) “Neuronal Serotonin.” J. Wiley and Sons, Chichester, Amsterdam, p. 555.
Pazos, A. and Palacios, J. M. (1985) Brain Res. 346, 205–230.
Pazos, A., Hoyer, D., and Palacios, J. M. (1985) Eur. J. Pharmacol. 106 539–546.
Pazos, A., Cortes, R., and Palacios, J. M. (1985a) Brain Res. 346, 231–249.
Pedigo, N. W., Yamamura, H. I., and Nelson, D. L. (1981) J. Neurochem. 36,220–226.
Pritchett, D. B., Bach, A. W. J., Wozny, M., Taleb, O., Dal Toso, R., Shih, J. C., and Seeburg, P. H. (1988) EMBO J., 7,4135–4140.
Ransom, R. W., Asarch, K. B., and Shih, J. C. (1985) J. Neurochem. 46,68–75.
Ransom, R. W., Asarch, K. B., and Shih, J. C. (1986) J. Neurochem. 47,1066–1072.
Regan, J. W., Kobilka, T. S., Yang-Feng, T. L., Caron, M. G., Lefkowitz, R. J., and Kobilka, B. K. (1988) Proc. Natl. Acad. Sci. USA 85 6301–6305.
Richardson, B. P. and Engel, G. (1986) TINS 424–428.
Rousselle, J. C., Gillet, G., and Fillon, G. (1985) J. Pharmacol. (Paris) 16 421–438.
Saitoh, T. and Shih, J. C. (1987) J. Neurochem. 491361–1366.
Takeuchi, Y., Yang, W., and Shih, J. C. (1988) J. Neurochem. 511343–1349.
Tricklebank, M. D. (1985) Trends Pharmacol. Sci. 6 403–407.
Vandenberg, S. R., Allgren, R. L., Todd, R. D., and Ciaranello, R. D. (1983) Proc. Natl. Acad. Sci. USA 80 3508–3512.
Vergé, D., Daval, G., Marcinkiewicz, M., Patey, A., El Mestikawy, S., Gozlan, H., and Hamon, M. (1986) J. Neurosci. 6 3474–3482.
Wouters, W., Van Dun, J., Leysen, J. E., and Laduron, P. M. (1985) Eur. J. Pharmacol. 115 1–9.
Wouters, W., Van Dun, J., Leysen, J. E., and Laduron, P. M. (1987) FEBS Lett. 213 359–364.
Yagaloff, K. E. and Hartig, P. R. (1986) Mol. Pharrnacol. 29,120–125.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gozlan, H., El Mestikawy, S., Hamon, M. (1990). Purification and Cloning of Central Serotonin Receptors. In: Litwack, G. (eds) Receptor Purification. Receptor Purification, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0461-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0461-9_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6771-3
Online ISBN: 978-1-4612-0461-9
eBook Packages: Springer Book Archive